ID SPACH AC CVCL_E833 SY SPACHECO; SPL DR dbMHC; 49024 DR dbMHC; 49026 DR ECACC; 95042725 DR IHW; IHW09072 DR IHW; IHW09101 DR IPD-IMGT/HLA; 11396 DR IPD-IMGT/HLA; 11397 DR Wikidata; Q54955518 RX DOI=10.1007/978-1-4612-3552-1_2; RX DOI=10.1007/978-1-4612-3552-1_4; RX DOI=10.1007/978-1-4612-3552-1_5; RX DOI=10.1007/978-1-4612-3552-1_6; RX DOI=10.1007/978-1-4612-3552-1_7; RX PubMed=8813743; RX PubMed=28360230; RX PubMed=29171935; RX PubMed=30844424; CC Part of: 10th International Histocompatibility Workshop (10IHW) cell line panel. CC Population: Native South American; Warao. CC HLA typing: A*31:01:02:01; B*15:01:01:01; C*01:02:30; DPA1*01:03:01:15; DPB1*04:02:01:02; DQA1*04:01:01:07; DQB1*04:02:01:04; DRA*01:02:02; DRB1*08:02:01:01 (IPD-IMGT/HLA=11396). CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV). CC Omics: Genomics; MHC region sequencing. CC Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. CC Cell type: B-cell; CL=CL_0000236. OX NCBI_TaxID=9606; ! Homo sapiens (Human) SX Male AG Age unspecified CA Transformed cell line DT Created: 22-10-12; Last updated: 10-04-25; Version: 18 // RX DOI=10.1007/978-1-4612-3552-1_2; RA Yang S.Y., Milford E.L., Hammerling U., Dupont B.; RT "Description of the reference panel of B-lymphoblastoid cell lines for RT factors of the HLA system: the B-cell line panel designed for the RT Tenth International Histocompatibility Workshop."; RL (In book chapter) Immunobiology of HLA. Volume I. Histocompatibility testing 1987; Dupont B. (eds.); pp.11-19; Springer; New York; USA (1989). // RX DOI=10.1007/978-1-4612-3552-1_4; RA Mickelson E.M., Reinsmoen N.L., Robbins F.-M., Hartzman R.J., Odum N., RA Svejgaard A., Farrell C., Honeyman M.C., Flomenberg N., Sell T.W., RA Eckels D.D.; RT "HLA-Dw and HLA-DP typing of the reference panel of B-lymphoblastoid RT cell lines."; RL (In book chapter) Immunobiology of HLA. Volume I. Histocompatibility testing 1987; Dupont B. (eds.); pp.38-42; Springer; New York; USA (1989). // RX DOI=10.1007/978-1-4612-3552-1_5; RA Yang S.Y.; RT "Assignment of HLA-A and HLA-B antigens for the reference panel of RT B-lymphoblastoid cell lines determined by one-dimensional isoelectric RT focusing (lD-IEF) gel electrophoresis."; RL (In book chapter) Immunobiology of HLA. Volume I. Histocompatibility testing 1987; Dupont B. (eds.); pp.43-44; Springer; New York; USA (1989). // RX DOI=10.1007/978-1-4612-3552-1_6; RA Knowles R.W.; RT "Assignment of HLA-class II alpha and beta chain 2-D gel patterns for RT the workshop reference panel of B-lymphoblastoid cell lines."; RL (In book chapter) Immunobiology of HLA. Volume I. Histocompatibility testing 1987; Dupont B. (eds.); pp.44-46; Springer; New York; USA (1989). // RX DOI=10.1007/978-1-4612-3552-1_7; RA Flomenberg N.; RT "Assignment of T-cell-defined (TCD) HLA class II specificities for the RT reference panel of B-lymphoblastoid cell lines."; RL (In book chapter) Immunobiology of HLA. Volume I. Histocompatibility testing 1987; Dupont B. (eds.); pp.46-48; Springer; New York; USA (1989). // RX PubMed=8813743; DOI=10.1111/j.1399-0039.1996.tb02596.x; RA Prasad V.K., Yang S.Y.; RT "Allele assignment for HLA-A, -B, and -C genes to the Tenth RT International Histocompatibility Workshop cell lines."; RL Tissue Antigens 47:538-546(1996). // RX PubMed=28360230; DOI=10.1101/gr.213538.116; PMCID=PMC5411776; RA Norman P.J., Norberg S.J., Guethlein L.A., Nemat-Gorgani N., Royce T., RA Wroblewski E.E., Dunn T., Mann T., Alicata C., Hollenbach J.A., RA Chang W.-H., Shults Won M., Gunderson K.L., Abi-Rached L., Ronaghi M., RA Parham P.; RT "Sequences of 95 human MHC haplotypes reveal extreme coding variation RT in genes other than highly polymorphic HLA class I and II."; RL Genome Res. 27:813-823(2017). // RX PubMed=29171935; DOI=10.1111/tan.13184; RA Turner T.R., Hayhurst J.D., Hayward D.R., Bultitude W.P., Barker D.J., RA Robinson J., Madrigal J.A., Mayor N.P., Marsh S.G.E.; RT "Single molecule real-time DNA sequencing of HLA genes at ultra-high RT resolution from 126 international HLA and immunogenetics workshop cell RT lines."; RL HLA 91:88-101(2018). // RX PubMed=30844424; DOI=10.1016/j.humimm.2019.03.001; PMCID=PMC6599558; RA Creary L.E., Guerra S.G., Chong W., Brown C.J., Turner T.R., RA Robinson J., Bultitude W.P., Mayor N.P., Marsh S.G.E., Saito K., RA Lam K., Duke J.L., Mosbruger T.L., Ferriola D., Monos D.S., Willis A., RA Askar M., Fischer G.F., Saw C.L., Ragoussis J., Petrek M., RA Serra-Pages C., Juan Otero M., Stavropoulos-Giokas C., Dinou A., Ameen R., RA Al Shemmari S., Spierings E., Gendzekhadze K., Morris G.P., Zhang Q.-H., RA Kashi Z., Hsu S., Gangavarapu S., Mallempati K.C., Yamamoto F., RA Osoegawa K., Vayntrub T., Chang C.-J., Hansen J.A., RA Fernandez-Vina M.A.; RT "Next-generation HLA typing of 382 International Histocompatibility RT Working Group reference B-lymphoblastoid cell lines: report from the RT 17th International HLA and Immunogenetics Workshop."; RL Hum. Immunol. 80:449-460(2019). //